×
Back to Agenda
FDA Legislation 2025: How is Congress Preparing to Advance Innovation, Medical Product Safety, and FDA Funding?
Session Chair(s)
Jeffrey K. Francer, JD, MPA
Vice President, Head of Global Regulatory Policy & Strategy
Eli Lilly and Company, United States
The forum will explore key legislative proposals affecting FDA regulation of drugs and devices, while FDA and industry prepare to negotiate the next round of user fees and performance goals.
Learning Objective : Describe key legislative initiatives that could alter FDA's regulation of drugs and medical devices; Discuss the interplay between current FDA legislative proposals and the upcoming FDA user fee negotiations and legislation; Recognize the impact of legislative proposals on FDA and regulated industries.
Speaker(s)
Panelist
Andrea Stern Ferris, MBA
LUNGevity Foundation, United States
President and CEO
Panelist
Barrett Tenbarge, JD
Faegre Drinker, United States
Partner
Panelist
Elizabeth Jungman, JD, MPH
N/A, United States
Former FDA Chief of Staff
Panelist
Grace Graham
FDA, United States
Deputy Commissioner for Policy, Legislation, and International Affairs
Have an account?